<DOC>
	<DOCNO>NCT00649831</DOCNO>
	<brief_summary>This study compare clinical efficacy safety azithromycin amoxicillin-clavulanic acid , patient age 35 75 year , present exacerbation chronic bronchitis .</brief_summary>
	<brief_title>A Multicentre , Randomised , Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis</brief_title>
	<detailed_description />
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Bronchitis , Chronic</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<criteria>Outpatients present exacerbation chronic bronchitis include : chronic bronchitis obstructive respiratory disorder document forced expiratory volume 80 % high 35 % theoretical value , within previous 12 month ; think infectious origin Patient presenting associate sign exacerbation Patient present clinical sign suggestive pneumonopathy inclusion Patient require hospitalisation intensive care</criteria>
	<gender>All</gender>
	<minimum_age>36 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>